- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pharmaron Beijing Co Ltd (3759)
Pharmaron Beijing Co Ltd stock price live, this page displays HK 3759 stock exchange data. View the 3759 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pharmaron Beijing Co Ltd real time stock price chart below.
What Is the Pharmaron Beijing Co Ltd Stock Price Today?
The Pharmaron Beijing Co Ltd stock price today is 17.98.
What Is the Stock Symbol for Pharmaron Beijing Co Ltd?
The stock symbol for Pharmaron Beijing Co Ltd is ""3759.""
What Stock Exchange Does Pharmaron Beijing Co Ltd Trade On?
Pharmaron Beijing Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Pharmaron Beijing Co Ltd a Good Stock to Buy?
Determining whether Pharmaron Beijing Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 3759 quote. (ISIN: CNE100003PG4)
What Is the Pharmaron Beijing Co Ltd Stock Price Today?
The Pharmaron Beijing Co Ltd stock price today is 17.98.
What Is the Stock Symbol for Pharmaron Beijing Co Ltd?
The stock symbol for Pharmaron Beijing Co Ltd is ""3759.""
What Stock Exchange Does Pharmaron Beijing Co Ltd Trade On?
Pharmaron Beijing Co Ltd is listed and trades on the Hong Kong stock exchange.
Is Pharmaron Beijing Co Ltd a Good Stock to Buy?
Determining whether Pharmaron Beijing Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 3759 quote. (ISIN: CNE100003PG4)
17.98
-0.42(-2.28%)
Closed·
Fair Value
An estimate of a Pharmaron Beijing Co Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.90
19.06
52 wk Range
8.06
24.85
3759 Scorecard
Full Analysis
High shareholder yield
3759 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Pharmaron Beijing Co Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.9019.06
52 wk Range
8.0624.85
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.22%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.22%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
3759 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Pharmaron Beijing Co Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
21.28
Upside
+18.34%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Pharmaron Beijing Co Ltd Company Profile
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vitro biology, DMPK, in vivo pharmacology, and compound management services; chemistry, manufacturing, and controls services. It also provides clinical development services, including integrated radio labelled science, clinical development, and clinical trial recruitment services; safety assessment, integrated drug discovery, and bioanalysis services; and biologics and cell and gene therapy services, comprising biologics laboratory, biologics CDMO, cell and gene therapy laboratory, and gene therapy CDMO services. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Compare 3759 to Peers and Sector
Metrics to compare | 3759 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship3759PeersSector | |
|---|---|---|---|---|
P/E Ratio | 23.2x | 35.8x | −0.5x | |
PEG Ratio | 0.86 | 0.07 | 0.00 | |
Price/Book | 3.1x | 2.8x | 2.6x | |
Price / LTM Sales | 3.4x | 5.6x | 3.2x | |
Upside (Analyst Target) | 14.7% | 3.5% | 44.1% | |
Fair Value Upside | Unlock | 14.3% | 6.2% | Unlock |
Analyst Ratings
13 Buy
0 Hold
1 Sell
Ratings:
14 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 21.28
(+18.34% Upside)
Earnings
Latest Release
Apr 27, 2025
EPS / Forecast
0.1842 / 0.2087
Revenue / Forecast
3.29B / 3.62B
People Also Watch
FAQ
What Stock Exchange Does Pharmaron Beijing Co Ltd Trade On?
Pharmaron Beijing Co Ltd is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Pharmaron Beijing Co Ltd?
The stock symbol for Pharmaron Beijing Co Ltd is "3759."
What Is the Pharmaron Beijing Co Ltd Market Cap?
As of today, Pharmaron Beijing Co Ltd market cap is 47.32B.
What Is Pharmaron Beijing Co Ltd's Earnings Per Share (TTM)?
The Pharmaron Beijing Co Ltd EPS (TTM) is 1.06.
When Is the Next Pharmaron Beijing Co Ltd Earnings Date?
Pharmaron Beijing Co Ltd will release its next earnings report on 01 Sept 2025.
From a Technical Analysis Perspective, Is 3759 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Pharmaron Beijing Co Ltd Stock Split?
Pharmaron Beijing Co Ltd has split 2 times.
How Many Employees Does Pharmaron Beijing Co Ltd Have?
Pharmaron Beijing Co Ltd has 21370 employees.
What is the current trading status of Pharmaron Beijing Co Ltd (3759)?
As of 22 Jul 2025, Pharmaron Beijing Co Ltd (3759) is trading at a price of 17.98, with a previous close of 18.40. The stock has fluctuated within a day range of 17.90 to 19.06, while its 52-week range spans from 8.06 to 24.85.
What Is Pharmaron Beijing Co Ltd (3759) Price Target According to Analysts?
The average 12-month price target for Pharmaron Beijing Co Ltd is HKD21.27750547, with a high estimate of HKD33.73632385 and a low estimate of HKD11.00328228. 13 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +18.34% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.